Terms: = Endocrine gland cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
36 results:
1. NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian cancers to MEK Inhibition.
Llaurado Fernandez M; Hijmans EM; Gennissen AMC; Wong NKY; Li S; Wisman GBA; Hamilton A; Hoenisch J; Dawson A; Lee CH; Bittner M; Kim H; DiMattia GE; Lok CAR; Lieftink C; Beijersbergen RL; de Jong S; Carey MS; Bernards R; Berns K
Mol Cancer Ther; 2022 Dec; 21(12):1862-1874. PubMed ID: 36198031
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing map3k1 and activating autophagy.
Dai L; Zhang W; Wu X; Zhou S
J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
[TBL] [Abstract] [Full Text] [Related]
3. Small-molecule IKKβ activation modulator (IKAM) targets map3k1 and inhibits pancreatic tumor growth.
Napoleon JV; Sagar S; Kubica SP; Boghean L; Kour S; King HM; Sonawane YA; Crawford AJ; Gautam N; Kizhake S; Bialk PA; Kmiec E; Mallareddy JR; Patil PP; Rana S; Singh S; Prahlad J; Grandgenett PM; Borgstahl GEO; Ghosal G; Alnouti Y; Hollingsworth MA; Radhakrishnan P; Natarajan A
Proc Natl Acad Sci U S A; 2022 May; 119(18):e2115071119. PubMed ID: 35476515
[TBL] [Abstract] [Full Text] [Related]
4. Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.
Liontos M; Andrikopoulou A; Koutsoukos K; Markellos C; Skafida E; Fiste O; Kaparelou M; Thomakos N; Haidopoulos D; Rodolakis A; Dimopoulos MA; Zagouri F
J Ovarian Res; 2021 Nov; 14(1):148. PubMed ID: 34724958
[TBL] [Abstract] [Full Text] [Related]
5. Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer.
Mie T; Sasaki T; Takeda T; Okamoto T; Mori C; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Jpn J Clin Oncol; 2021 Aug; 51(9):1416-1422. PubMed ID: 34128055
[TBL] [Abstract] [Full Text] [Related]
6. EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian cancer Cells.
Poursheikhani A; Yousefi H; Tavakoli-Bazzaz J; Seyed H G
Iran Biomed J; 2020 Nov; 24(6):370-8. PubMed ID: 32660222
[TBL] [Abstract] [Full Text] [Related]
7. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract] [Full Text] [Related]
8. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of stimulus-induced interleukin-8 gene transcription in human adrenocortical carcinoma cells - Role of AP-1 and NF-κB.
Thiel G; Ulrich M; Mukaida N; Rössler OG
Cytokine; 2020 Feb; 126():154862. PubMed ID: 31634687
[TBL] [Abstract] [Full Text] [Related]
10. Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian cancer.
Van Nieuwenhuysen E; Busschaert P; Laenen A; Moerman P; Han SN; Neven P; Lambrechts D; Vergote I
Neoplasia; 2019 Jun; 21(6):582-590. PubMed ID: 31054497
[TBL] [Abstract] [Full Text] [Related]
11. Identification of the risk factors of the thyroid cancer by using logit model in Lahore.
Asif F; Noor-Ul-Amin M; Ahmad MR
Pak J Pharm Sci; 2018 Nov; 31(6):2391-2396. PubMed ID: 30473509
[TBL] [Abstract] [Full Text] [Related]
12. Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Jara L; Morales S; de Mayo T; Gonzalez-Hormazabal P; Carrasco V; Godoy R
Biol Res; 2017 Oct; 50(1):35. PubMed ID: 28985766
[TBL] [Abstract] [Full Text] [Related]
13. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract] [Full Text] [Related]
14. Swyer syndrome.
King TF; Conway GS
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):504-10. PubMed ID: 25314337
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network
Nature; 2012 Oct; 490(7418):61-70. PubMed ID: 23000897
[TBL] [Abstract] [Full Text] [Related]
16. [Implications of genetic risk factors in breast cancer: culprit genes and associated malignancies].
Stoppa-Lyonnet D; Buecher B; Houdayer C; de Pauw A; Gauthier-Villars M; de la Rochefordière A; This P; Asselain B; Andrieu N
Bull Acad Natl Med; 2009 Dec; 193(9):2063-83; discussion 2084-5. PubMed ID: 20690207
[TBL] [Abstract] [Full Text] [Related]
17. Roles of LPA in ovarian cancer development and progression.
Pua TL; Wang FQ; Fishman DA
Future Oncol; 2009 Dec; 5(10):1659-73. PubMed ID: 20001802
[TBL] [Abstract] [Full Text] [Related]
18. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
[TBL] [Abstract] [Full Text] [Related]
19. Depleting mekk1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Su F; Li H; Yan C; Jia B; Zhang Y; Chen X
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1655-63. PubMed ID: 19513748
[TBL] [Abstract] [Full Text] [Related]
20. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
[TBL] [Abstract] [Full Text] [Related]
[Next]
